- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 90.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 90.77M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 82.41M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $176K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $1.26M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$13.15M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$13.8M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $40.48M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $40.11M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $28.57M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $27.42M |
| Short Term Investments restated | Q1 2026 · Mar 31, 2025 | $41.5M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $36.57M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $50.79M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $18.32M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $43.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $50.53M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $49.63M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $66.93M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $14.85M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $25.32M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $86.14M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $97.27M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $79.65M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $96.82M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $129.37M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $147.8M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.10 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.25 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.78M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $12.36M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $11.45M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $12.94M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$8.7M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$20.69M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.04M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$20.49M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.06M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.73M |
| Revenue | Q1 2026 · Mar 31, 2026 | $15.25M |
| Revenue | Q1 2026 · Mar 31, 2025 | $7.54M |